Patent litigation attorney

Michael F. Milea

4 tracked appearances — 1 plaintiff · 3 defendant.

Specialty & background

Michael F. Milea — Counsel, Groombridge, Wu, Baughman & Stone LLP (New York)

Specialty / focus areas. Milea's tracked district court work centers on geospatial and aerial-imagery software: both of his logged appearances are for Nearmap in Eagle View Technologies, Inc. v. Nearmap US, Inc. (D. Utah, No. 2:21-cv-00283), a multi-patent dispute over automated roof-measurement and 3D building-reconstruction technology. His wider docket record shows a broader technical range, including pharmaceuticals and biologics — he is listed on the Groombridge Wu team for Amgen in the Ossifi-MAB dispute over Evenity (romosozumab) antibody patents and for Novo Nordisk in the semaglutide/Ozempic-Wegovy patent litigation and related PTAB matters. His firm bio also notes a civil-engineering background (B.S., Rutgers) and prior work as a heavy-highway project engineer, which aligns with the construction/aerial-survey subject matter of the Nearmap matter.

Side preference. On the two tracked district court appearances he is defense-side (0 plaintiff / 2 defendant). His broader docket record is more mixed: PTAB filings and mandatory notices show him acting for patent owners (Novo Nordisk, and Twitter/X in the PARC litigation per firm rankings) as well as for petitioners (Uber Technologies; Atossa Therapeutics in PGR2026-00015 against Jina Pharmaceuticals). The overall pattern is representation of established operating companies rather than NPE-side assertion, though he has appeared for a brand-name pharmaceutical plaintiff (Vanda) in district court filings that predate the tracked window.

Firm context. He is counsel at Groombridge, Wu, Baughman & Stone LLP, the patent litigation boutique founded by former Paul, Weiss IP partners. He previously practiced at Paul, Weiss, Rifkind, Wharton & Garrison, where he co-authored client alerts on patent venue (In re Google), patent eligibility, and Appointments Clause challenges to PTAB judges, and where he first appeared alongside the Groombridge Wu name partners. A December 2022 district court notice of change of firm affiliation reflects his move to the new firm. Per his firm bio, he also had a stint as a law clerk at the U.S. International Trade Commission's Office of Unfair Investigation (this detail is sourced from a professional profile rather than an independent record).

Notable cases, PTAB/IPR, and bar/education. In the Nearmap matter, the PTAB found the asserted EagleView aerial-roof-estimation claims unpatentable as obvious, and the Federal Circuit affirmed (No. 24-1488, nonprecedential, Feb. 3, 2026); the companies separately announced a settlement of the Utah litigation in May 2026 with confidential terms. He was also part of the Groombridge Wu team recognized as an American Lawyer "Litigator of the Week" runner-up for Amgen's summary-judgment win invalidating the Ossifi-MAB Evenity patents (D. Mass.). He appears regularly in PTAB post-grant practice — listed as backup counsel in Novo Nordisk IPRs (e.g., IPR2023-00724, IPR2024-00631), on Uber's IPR power of attorney, and as petitioner's counsel in the Atossa v. Jina PGR. He is registered with the USPTO (Reg. No. 71,863), admitted in New York and before the Federal Circuit, E.D.N.Y., and S.D.N.Y., and holds a B.S. in Civil Engineering from Rutgers (cum laude) and a J.D. from Georgetown University Law Center (cum laude).

Caveat: some details above (prior employment, firm-affiliation timing) are drawn from docket filings and a professional profile rather than a single authoritative source; I did not locate a published trial verdict attributed to him individually.

Firms

Roles

  • counsel for petitioner1
  • back-up counsel1
  • counsel1
  • trial/appellate counsel1

Cases (4)